Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Amortizatization of Intangibles (2016 - 2023)

Neuroone Medical Technologies (NMTC) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $4568.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Amortizatization of Intangibles changed N/A year-over-year to $4568.0, compared with a TTM value of $45571.0 through Sep 2023, changed N/A, and an annual FY2023 reading of $45571.0, up 297.27% over the prior year.
  • Amortizatization of Intangibles was $4568.0 for Q2 2023 at Neuroone Medical Technologies, down from $20238.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $20765.0 in Q4 2022 and bottomed at $4568.0 in Q2 2023.